Market Insight

Boustead Singapore Limited has acquired a 60% stake in UroMedTech Pte Ltd through a S$6 million equity investment, expanding its healthcare technology portfolio.
UroMedTech develops the UroMaster robotic platform for prostate cancer diagnosis, which is approved in Singapore, Malaysia, Australia, and

Median Technologies has announced that its AI-powered software, eyonis® LCS, has obtained CE marking as a Class IIb medical device. Granted by the French notified body GMED, this certification confirms compliance with European standards for patient safety and clinical efficacy, allowing the company

Materna Medical, a Mountain View, California-based OBGYN platform company, has successfully closed a $5 million B3 financing round. The investment was led by InnovaHealth Partners, Wavemaker360 Health, and Band of Angels, with participation from existing investors. This new capital positions the com

Francis Medical has published the initial report of its VAPOR 2 pivotal clinical study in The Journal of Urology, showcasing highly positive results for its Vanquish Water Vapor Ablation System. The trial evaluated the first 110 patients diagnosed with localized, intermediate-risk prostate cancer ac

Pacira BioSciences has agreed to sell its Iovera nerve therapy device to orthopedic giant Zimmer Biomet in a transaction valued at up to $140 million. Under the terms of the agreement, Zimmer Biomet will provide an upfront payment of $70 million, with the remaining $70 million structured as potentia

Novocure has successfully secured CE mark approval in Europe for its Optune Pax device, a wearable system designed to treat adults with locally advanced pancreatic cancer. The portable device works by delivering noninvasive, alternating electrical fields- known as Tumor Treating Fields (TTFields) -

Bioness Medical has received FDA 510(k) clearance for its PoNS (Portable Neuromodulation Stimulator) system to treat dynamic gait deficit caused by chronic stroke symptoms. This regulatory milestone significantly expands the commercial indications for the device, building upon its previous authoriza

United Therapeutics announced that the US Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for its LungFX perfusion device. The system, which received regulatory clearance through United Therapeutics’ wholly owned subsidiary, Lung Bioengineering Inc., is explicitly designed fo

Cork-based medical technology company NeuroBell has successfully secured $5.5 million (€4.8 million) in a new investment round to accelerate the United States launch of its LUNA neonatal brain monitor. The funding round was led by Elkstone and saw participation from major existing investors alongsid